Jon Congleton Insider Trades & Stock Holdings

Chief Executive Officer · Mineralys Therapeutics, Inc. · Latest filing Jun 30, 2026

Jon Congleton, Chief Executive Officer at Mineralys Therapeutics, Inc. has 2 Form 4 trades on file since Jun 29, 2026 across 2 companies. Open-market activity: 0 purchases ($0) and 1 sale ($1.96M), net -$1.96M. Latest filing: disposed of 75K shares of $MLYS on Jun 30, 2026 at $26.14.

Trades on file: 2
Open-market bought: $0
Open-market sold: $1.96M
Net open-market: -$1.96M
Latest filing: Jun 30, 2026

All insider trades by Jon Congleton

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 30, 2026	$MLYS	Sell (Open-market sale) 10b5-1	75K	$26.14	$1.96M			+12.9%	-2.9%		Chief Executive Officer		Read
Jun 29, 2026	$IMUX	Buy (Grant or award)	50.74K	$0	—			-3.6%	-15.3%				Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Jon Congleton traded

Frequently asked questions

Has Jon Congleton been buying or selling stock?

Jon Congleton has 0 open-market purchases and 1 open-market sale on file, net -$1.96M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Jon Congleton's latest insider trade?

disposed of 75K shares of $MLYS on Jun 30, 2026 at $26.14.

All insiders Insider cluster buys Top insider purchases Latest insider trade news

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text